Skip to main content

CD72

  • Reference work entry
  • First Online:

Synonyms

CD72 antigen; Ly-19; Ly-32; Ly-m19; Lyb-2

Historical Background

B lymphocytes express several surface molecules other than the B cell receptors (BCR) that function as markers of differentiation as well as molecules that can fine tune BCR signaling. Current research has identified a function for most antigens that were previously classified as markers of lymphocyte differentiation. CD72 is one such molecule that was originally discovered as a marker of B cell differentiation using conventional serological and classical genetic techniques. Subsequently generation of monoclonal antibodies helped its definition as a molecule that can affect B cell growth and differentiation on its own or in the context of BCR signaling. Initially Sato and Boyse described an activity in sera from C3H.I mice immunized with 1.29 ascites tumor cells that reacted only with a subset of spleen cells after it was absorbed to remove an unknown reactivity. Subsequently the cell type in the spleen recognized...

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   4,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   4,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Adachi T, Wakabayashi C, Nakayama T, Yakura H, Tsubata T. CD72 negatively regulates signaling through the antigen receptor of B cells. J Immunol. 2000;164:1223–9.

    Article  PubMed  CAS  Google Scholar 

  • Akatsu C, Shinagawa K, Numoto N, Liu Z, Ucar AK, Aslam M, Phoon S, Adachi T, Furukawa K, Ito N, Tsubata T. CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP. J Exp Med. 2016;213:2691–706.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Alcón VL, Luther C, Balce D, Takei F. B-cell co-receptor CD72 is expressed on NK cells and inhibits IFN-γ production but not cytotoxicity. Eur J Immunol. 2009;39:826–32.

    Article  PubMed  CAS  Google Scholar 

  • Berland R, Fernandez L, Kari E, Han JH, Lomakin I, Akira S, Wortis HH, Kearney JF, Ucci AA, Imanishi-Kari T. Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity. 2006;25:429–40.

    Article  PubMed  CAS  Google Scholar 

  • Besliu A, Banica L, Predeteanu D, Vlad V, Ionescu R, Pistol G, Opris D, Berghea F, Stefanescu M, Matache C. Peripheral blood lymphocytes analysis detects CD100/SEMA4D alteration in systemic sclerosis patients. Autoimmunity. 2011;44:427–36.

    Article  PubMed  CAS  Google Scholar 

  • Bikah G, Lynd FM, Aruffo AA, Ledbetter JA, Bondada S. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5. Int Immunol. 1998;10:1185–96.

    Article  PubMed  CAS  Google Scholar 

  • Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006;25:417–28.

    Article  PubMed  CAS  Google Scholar 

  • Deaglio S, Vaisitti T, Bergui L, Bonello L, Horenstein AL, Tamagnone L, Boumsell L, Malavasi F. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood. 2005;105:3042–50.

    Article  PubMed  CAS  Google Scholar 

  • Eriksson EM, Milush JM, Ho EL, Batista MD, Holditch SJ, Keh CE, Norris PJ, Keating SM, Deeks SG, Hunt PW, Martin JN, Rosenberg MG, Hecht FM, Nixon DF. Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity. Blood. 2012;119:745–55.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Fusaki N, Tomita S, Wu Y, Okamoto N, Goitsuka R, Kitamura D, Hozumi N. BLNK is associated with the CD72/SHP-1/grb2 complex in the WEHI231 cell line after membrane IgM cross-linking. Eur J Immunol. 2000;30:1326–30.

    Article  PubMed  CAS  Google Scholar 

  • Gustin SE, Thien CB, Langdon WY. Cbl-b is a negative regulator of inflammatory cytokines produced by IgE-activated mast cells. J Immunol. 2006;177:5980–9.

    Article  PubMed  CAS  Google Scholar 

  • Han S, Zhuang H, Shumyak S, Yang L, Reeves WH. Mechanisms of autoantibody production in systemic lupus erythematosus. Front Immunol. 2015;6:228.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • He Y, Guo Y, Zhou Y, Zhang Y, Fan C, Ji G, Wang Y, Ma Z, Lian J, Hao C, Yao ZQ, Jia Z. CD100 up-regulation induced by interferon-alpha on B cells is related to hepatitis C virus infection. PLoS One. 2014;9:e113338.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hitomi Y, Tsuchiya N, Kawasaki A, Kyogoku C, Ohashi J, Suzuki T, Fukazawa T, Bejrachandra S, Siriboonrit U, Chandanayingyong D, Suthipinittharm P, Tsao BP, Hashimoto H, Honda Z-I, Tokunaga K. CD72 polymorphisms associated with alternative splicing modify susceptibility to human systemic lupus erythematosus through epistatic interaction with FCGR2B. Hum Mol Genet. 2004 Dec 1;13(23):2907–17.

    Google Scholar 

  • Hitomi Y, Adachi T, Tsuchiya N, Honda Z-I, Tokunaga K, Tsubata T. Human CD72 splicing isoform responsible for resistance to systemic lupus erythematosus regulates serum immunoglobulin level and is localized in endoplasmic reticulum. BMC Immunol. 2012;13:72.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B’-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med. 1995;181:453–61.

    Article  PubMed  CAS  Google Scholar 

  • Kataoka TR, Kumanogoh A, Bandara G, Metcalfe DD, Gilfillan AM. CD72 negatively regulates KIT-mediated responses in human mast cells. J Immunol. 2010;184:2468–75.

    Article  PubMed  CAS  Google Scholar 

  • Kataoka TR, Kumanogoh A, Hirata M, Moriyoshi K, Ueshima C, Kawahara M, Tsuruyama T, Haga H. CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1. Sci Rep. 2013;3:2861.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kataoka TR, Kumanogoh A, Fukuishi N, Ueshima C, Hirata M, Moriyoshi K, Tsuruyama T, Haga H. CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcepsilonRIalpha. Int Immunol. 2015;27:95–103.

    Article  PubMed  CAS  Google Scholar 

  • Kikutani H, Kumanogoh A. Semaphorins in interactions between T cells and antigen-presenting cells. Nat Rev Immunol. 2003;3:159–67.

    Article  PubMed  CAS  Google Scholar 

  • Kuklina EM, Baidina TV, Danchenko IY, Nekrasova IV. Semaforin Sema4D in the immune system in multiple sclerosis. Bull Exp Biol Med. 2014;157:234–7.

    Article  PubMed  CAS  Google Scholar 

  • Kumanogoh A, Kikutani H. Biological functions and signaling of a transmembrane semaphorin, CD100/Sema4D. Cell Mol Life Sci. 2004;61:292–300.

    Article  PubMed  CAS  Google Scholar 

  • Kumanogoh A, Shikina T, Watanabe C, Takegahara N, Suzuki K, Yamamoto M, Takamatsu H, Prasad DV, Mizui M, Toyofuku T, Tamura M, Watanabe D, Parnes JR, Kikutani H. Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment. Int Immunol. 2005;17:1277–82.

    Article  PubMed  CAS  Google Scholar 

  • Li DH, Winslow MM, Cao TM, Chen AH, Davis CR, Mellins ED, Utz PJ, Crabtree GR, Parnes JR. Modulation of peripheral B cell tolerance by CD72 in a murine model. Arthritis Rheum. 2008;58:3192–204.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Liu B, Ma Y, Yi J, Xu Z, Zhang YS, Zhang C, Zhuang R, Yu H, Wang J, Yang A, Zhang Y, Jin B. Elevated plasma soluble Sema4D/CD100 levels are associated with disease severity in patients of hemorrhagic fever with renal syndrome. PLoS One. 2013;8:e73958.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Liu B, Ma Y, Zhang Y, Zhang C, Yi J, Zhuang R, Yu H, Yang A, Zhang Y, Jin B. CD8low CD100- T cells identify a novel CD8 T cell subset associated with viral control during human hantaan virus infection. J Virol. 2015;89:11834–44.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lu J, Li J, Zhu TQ, Zhang L, Wang Y, Tian FF, Yang H. Modulation of B cell regulatory molecules CD22 and CD72 in myasthenia gravis and multiple sclerosis. Inflammation. 2013;36:521–8.

    Article  PubMed  CAS  Google Scholar 

  • Mimori K, Kiyokawa N, Taguchi T, Suzuki T, Sekino T, Nakajima H, Saito M, Katagiri YU, Isoyama K, Yamada K, Matsuo Y, Fujimoto J. Costimulatory signals distinctively affect CD20- and B-cell-antigen-receptor-mediated apoptosis in Burkitt’s lymphoma/leukemia cells. Leukemia. 2003;17:1164–74.

    Article  PubMed  CAS  Google Scholar 

  • Mizui M, Kumanogoh A, Kikutani H. Immune semaphorins: novel features of neural guidance molecules. J Clin Immunol. 2009;29:1–11.

    Article  PubMed  CAS  Google Scholar 

  • Myers DE, Uckun FM. An anti-CD72 immunotoxin against therapy-refractory B-lineage acute lymphoblastic leukemia. Leuk Lymphoma. 1995;18:119–22.

    Article  PubMed  CAS  Google Scholar 

  • Nakayama E, von Hoegen I, Parnes JR. Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation. Proc Natl Acad Sci USA. 1989;86:1352–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Ogimoto M, Ichinowatari G, Watanabe N, Tada N, Mizuno K, Yakura H. Impairment of B cell receptor-mediated Ca2+ influx, activation of mitogen-activated protein kinases and growth inhibition in CD72-deficient BAL-17 cells. Int Immunol. 2004;16:971–82.

    Article  PubMed  CAS  Google Scholar 

  • Oishi H, Tsubaki T, Miyazaki T, Ono M, Nose M, Takahashi S. A bacterial artificial chromosome transgene with polymorphic Cd72 inhibits the development of glomerulonephritis and vasculitis in MRL-Faslpr lupus mice. J Immunol. 2013;190:2129–37.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Pan C, Baumgarth N, Parnes JR. CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation. Immunity. 1999;11:495–506.

    Article  PubMed  CAS  Google Scholar 

  • Planken EV, Van de Velde H, Falkenburg JH, Thielemans K, Willemze R, Kluin-Nelemans JC. Selective response of CD5+ B cell malignancies to activation of the CD72 antigen. Clin Immunol Immunopathol. 1998;87:42–9.

    Article  PubMed  CAS  Google Scholar 

  • Robinson WH, Ying H, Miceli MC, Parnes JR. Extensive polymorphism in the extracellular domain of the mouse B cell differentiation antigen Lyb-2/CD72. J Immunol. 1992;149:880–6.

    PubMed  CAS  Google Scholar 

  • Robinson WH, Landolfi MMT, Schafer H, Parnes JR. Biochemical identity of the mouse Ly-19.2 and 32.2 alloantigens with the B cell differentiation antigen Lyb-2/CD72. J Immunol. 1993;151:4764–72.

    PubMed  CAS  Google Scholar 

  • Rojas A, Xu F, Rojas M, Thomas JW. Structure and function of CD72 in the non-obese diabetic (NOD) mouse. Autoimmunity. 2003;36:233–9.

    Article  PubMed  CAS  Google Scholar 

  • Sato H, Boyse EA. A new alloantigen expressed selectively on B cells: the Lyb-2 system. Immunogenetics. 1976;3:565–72.

    Article  Google Scholar 

  • Schwarting R, Castello R, Moldenhauer G, Pezzutto A, von Hoegen I, Ludwig WD, Parnes JR, Dorken B. Human Lyb-2 homolog CD72 is a marker for progenitor B-cell leukemias. Am J Hematol. 1992;41:151–8.

    Article  PubMed  CAS  Google Scholar 

  • Subbarao B, Mosier DE. Induction of B lymphocyte proliferation without antibody secretion by monoclonal anti-Lyb2 antibody. J Immunol. 1983;130:2033–7.

    PubMed  CAS  Google Scholar 

  • Tung JS, Shen FW, LaRegina V, Boyse EA. Antigenic complexity and protein-structural polymorphism in the Lyb-2 system. Immunogenetics. 1986;23:208–10.

    Article  PubMed  CAS  Google Scholar 

  • Vadasz Z, Haj T, Balbir A, Peri R, Rosner I, Slobodin G, Kessel A, Toubi E. A regulatory role for CD72 expression on B cells in systemic lupus erythematosus. Semin Arthritis Rheum. 2014;43:767–71.

    Article  PubMed  CAS  Google Scholar 

  • Vadasz Z, Goldeberg Y, Halasz K, Rosner I, Valesini G, Conti F, Perricone C, Sthoeger Z, Bezalel SR, Tzioufas AG, Levin NA, Shoenfeld Y, Toubi E. Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis. Clin Immunol. 2016;164:114–8.

    Article  PubMed  CAS  Google Scholar 

  • Wu H-J. The positive signaling role of CD72 in B lymphocyte activation and function (doctoral thesis). In: Microbiology, immunology and molecular genetics. University of Kentucky, Lexington; 2002.

    Google Scholar 

  • Wu H-J, Bondada S. Positive and negative roles of CD72 in B cell function. Immunol Res. 2002;25:155–66.

    Article  PubMed  CAS  Google Scholar 

  • Wu HJ, Bondada S. CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function. J Clin Immunol. 2009;29:12–21.

    Article  PubMed  CAS  Google Scholar 

  • Wu Y, Nadler MJ, Brennan LA, Gish GD, Timms JF, Fusaki N, Jongstra-Bilen J, Tada N, Pawson T, Wither J, Neel BG, Hozumi N. The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1. Curr Biol. 1998;8:1009–17.

    Article  PubMed  CAS  Google Scholar 

  • Wu HJ, Venkataraman C, Estus S, Dong C, Davis RJ, Flavell RA, Bondada S. Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation. J Immunol. 2001;167:1263–73.

    Article  PubMed  CAS  Google Scholar 

  • Xu M, Hou R, Sato-Hayashizaki A, Man R, Zhu C, Wakabayashi C, Hirose S, Adachi T, Tsubata T. Cd72c is a modifier gene that regulates faslpr-induced autoimmune disease. J Immunol. 2013;190:5436–45.

    Article  PubMed  CAS  Google Scholar 

  • Yakura H, Shen F-W, Bourcet E, Boyse EA. Evidence that Lyb-2 is critical to specific activation of B cells before they become responsive to T and other signals. J Exp Med. 1982;155:1309.

    Article  PubMed  CAS  Google Scholar 

  • Ying H, Nakayama E, Robinson WH, Parnes JR. Structure of the mouse CD72 (Lyb-2) gene and its alternatively spliced transcripts. J Immunol. 1995;155:1637.

    PubMed  CAS  Google Scholar 

  • Zhou H, Qi AP, Li HY, Ma L, Xu JH, Xue F, Lu SH, Zhao QJ, Zhou ZP, Yang RC. CD72 gene expression in immune thrombocytopenia. Platelets. 2012;23:638–44.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hsin-Jung Wu .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Wu, HJ., Muthusamy, N., Bondada, S. (2018). CD72. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_461

Download citation

Publish with us

Policies and ethics